News
-
Eagle eyes Rabbitohs and Wararahs
Monday | Mar 12 2018EAGLE Natural Health has announced a partnership with NSW football clubs, the Waratahs and Rabbitohs as their official nutritional supplier in supporting both teams' everyday performance.
-
Weekly Comment
Monday | Mar 12 2018
12 Mar 18 The bumpy road to buying your first pharmacyWELCOME to PD's weekly comment feature.
-
Events Calendar 09 Mar 18
Friday | Mar 9 201816-18 Mar: Annual Therapeutic Update 2018; Fairmont Resort, Blue Mountains; for details and registrations visit: www.psa.org.au,.
-
Blackmores/CCNB honour Meads-Barlow
Friday | Mar 9 2018TYPE 1 diabetes activist Donna Meads-Barlow was yesterday named as the inaugural winner of the Blackmores.
-
Dispensary Corner
Friday | Mar 9 2018
09 Mar 18A british man suspected of swallowing a drug stash has been freed after he refused to go to the toilet for over six weeks.
-
EpiPen supply hope
Friday | Mar 9 2018THE Pharmacy Guild of Australia has advised there are now limited stocks of EpiPens coming into Australia, with more received last week and now in the process of being labelled and distributed.
-
Apr price disclosure
Friday | Mar 9 2018THE summary of price disclosure price reductions and Indicative prices for the 2018 April Cycle (Fourth Remove Originator cycle) have now been updated on the Price Disclosure web page, the Pharmaceutical Benefits Scheme has advised.
-
Temple Touch recall
Friday | Mar 9 2018TOLIFE Technologies, in consultation with the Therapeutic Goods Administration (TGA), is recalling one lot of its Rite Aid Mini Digital Temple Touch Thermometer as the battery compartment is not adequately secured, allowing access to the button battery inside.
-
Ja Dera Max+ risk
Friday | Mar 9 2018THE Therapeutic Goods Administration (TGA) warns it has tested a product labelled Ja Dera Max+ capsules and found that it contains the undeclared prescription-only anaesthetic lignocaine, posing a risk to health.
-
Clinical trials handbook update
Friday | Mar 9 2018THE Therapeutic Goods Administration (TGA) has provided an update on its Australian clinical trial handbook, giving sponsors guidance on legislative, regulatory and good clinical practice (GCP) requirements when conducting clinical trials in Australia using 'unapproved' therapeutic goods.
